Abbott's segment revenues 2017-2022

Abbot Laboratories is an international medtech and pharmaceutical company headquartered in Chicago, Illinois. In 2013, Abbott Laboratories was split into two companies: Abbot (medical products) and AbbVie (research-based pharmaceuticals). As of 2022, the diagnostics segment was the largest segment within the company and generated 16.6 billion U.S. dollars in revenues. Abbot’s medical devices segment also generated a significant amount for the company with 15.6 billion U.S. dollars in revenue during that year.

Abbott’s company profile

Abbott Laboratories was founded in 1888 in Chicago, where the company has remained since. The company operates in around 160 countries globally, covering therapeutic areas such as diabetes, diagnostics, nutrition and cardiovascular disease. The number of employees at Abbot Laboratories (Abbot and AbbVie) has increased over the last several years. The revenues of Abbott declined around the time the company was split in 2013 but has increased significantly in recent years.

Abbott’s global positioning

Abbot Laboratories is among the top global health companies in many regards. Abbot was ranked fourth among other biopharmaceutical companies worldwide based on market capitalization. In the meantime, AbbVie, Abbott Laboratories’ spin-off company, was ranked 10th among the top global pharmaceutical companies based on prescription sales.